Is Mitochondrial Oxidative Stress a Viable Therapeutic Target in Preeclampsia?

Abstract excerpt

Despite considerable research efforts over the past few decades, the pathology of preeclampsia (PE) remains poorly understood with no new FDA-approved treatments. There is a substantial amount of work being conducted by investigators around the world to identify targets to develop therapies for PE. Oxidative stress has been identified as one of the crucial players in pathogenesis of PE and has garnered a great...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Birth, Development, and Health
• Share to Neurological Complications and Syndromes
• Share to Pregnancy and preeclampsia studies